Breaking News Instant updates and real-time market news.

FAST

Fastenal

$35.95

-0.41 (-1.13%)

, AMCX

AMC Networks

$46.77

-1.65 (-3.41%)

10:09
10/14/19
10/14
10:09
10/14/19
10:09

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fastenal (FAST) downgraded to Market Perform from Strong Buy at Raymond James and to Equal Weight from Overweight at Stephens. 2. AMC Networks (AMCX) downgraded to Underperform from In Line at Evercore ISI with analyst David Joyce saying given his industry view of accelerating cord-cutting trends, the analyst views AMC's reward/risk tradeoff as unfavorable at current share levels. 3. Delta Air Lines (DAL) downgraded to Equal Weight from Overweight at Stephens with analyst Jack Atkins saying investors are "understandably frustrated" that despite a highly favorable operating environment this year, Delta is unable to more aggressively drive yields higher. 4. Toll Brothers (TOL) downgraded to Neutral from Positive at Susquehanna with analyst Jack Micenko saying the shares have outperformed the S&P and are now at the high end of their historical average forward P/E. 5. Canopy Growth (CGC) and Hexo (HEXO) downgraded to Neutral from Buy at Seaport Global. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

FAST

Fastenal

$35.95

-0.41 (-1.13%)

AMCX

AMC Networks

$46.77

-1.65 (-3.41%)

DAL

Delta Air Lines

$52.44

-0.5 (-0.94%)

TOL

Toll Brothers

$39.32

-0.17 (-0.43%)

CGC

Canopy Growth

$18.66

-0.76 (-3.91%)

HEXO

Hexo

$2.38

-0.155 (-6.11%)

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 12

    Nov

  • 12

    Nov

FAST Fastenal
$35.95

-0.41 (-1.13%)

10/14/19
SPHN
10/14/19
DOWNGRADE
Target $37
SPHN
Equal Weight
Fastenal downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Blake Hirschman downgraded Fastenal to Equal Weight from Overweight with a price target of $37, up from $36. The analyst continues to see the company as the industrial distributor best positioned to combat a softening end market environment. However, with the stock sitting near all-time highs, and given his expectation of slowdown in the company's core manufacturing end market, he struggles to find "meaningful near-to-medium term upside" in the stock from current levels.
10/14/19
RAJA
10/14/19
DOWNGRADE
RAJA
Market Perform
Fastenal double downgraded to Market Perform at Raymond James
Raymond James analyst Samuel Darkatsh double downgraded to Market Perform from Strong Buy citing valuation with the shares approaching his prior $37 price target. Darkatsh cites three factors for the downgrade: Softening broad demand, including weak railcar shipments; that valuation now implies implies bullish market assumptions for long-term organic growth rates for mature branches; and that the stock's historical correlation with the company's ROTNA now suggests limited further upside. The analyst now sees 2019 EPS of $1.39 from $1.38 prior and continues to see 2020 EPS of $1.49.
10/14/19
RAJA
10/14/19
DOWNGRADE
RAJA
Market Perform
Fastenal downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst Samuel Darkatsh double downgraded to Market Perform from Strong Buy citing valuation with the shares approaching his prior price target.
10/14/19
SPHN
10/14/19
DOWNGRADE
SPHN
Equal Weight
Fastenal downgraded to Equal Weight from Overweight at Stephens
AMCX AMC Networks
$46.77

-1.65 (-3.41%)

07/30/19
WOLF
07/30/19
UPGRADE
WOLF
Peer Perform
AMC Networks upgraded to Peer Perform from Underperform at Wolfe Research
Wolfe Research analyst Marci Ryvicker upgraded AMC Networks to Peer Perform from Underperform.
10/14/19
EVER
10/14/19
DOWNGRADE
EVER
Underperform
AMC Networks downgraded to Underperform from In Line at Evercore ISI
09/23/19
WELS
09/23/19
INITIATION
Target $58
WELS
Market Perform
AMC Networks initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Steven Cahall started AMC Networks with a Market Perform rating and $58 price target. The analyst thinks AMC would fit better as part of a larger Media enterprise but he does not see any near-term buyers.
10/14/19
EVER
10/14/19
DOWNGRADE
Target $50
EVER
Underperform
Evercore downgrades AMC Networks to Underperform on cord-cutting trends
Evercore ISI analyst David Joyce downgraded AMC Networks to Underperform from In Line with a price target of $50, down from $60. Given his industry view of accelerating cord-cutting trends, the analyst views AMC's reward/risk tradeoff as unfavorable at current share levels. The domestic affiliate fee environment has been challenging for AMC Networks and the industry as a whole, Joyce tells investors in a research note. Much of the bear case surrounding AMC shares hinges on the potential that a significant distributor could drop AMC's channels in the near-term, adds the analyst. Joyce's "base case" assumes the expected upcoming carriage renewal gets completed, but with no step-up in rate.
DAL Delta Air Lines
$52.44

-0.5 (-0.94%)

10/11/19
10/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Crowdstrike (CRWD) downgraded to Sell from Neutral at Goldman Sachs with analyst Heather Bellini stating while CrowdStrike is very well positioned in the market for endpoint security, a "blue sky analysis" suggests this is likely priced in at current share levels. 2. Terex (TEX) downgraded to Underweight from Equal Weight at Barclays with analyst Adam Seiden expecting the rental equipment market to move from equilibrium to oversupplied by 2020. 3. Delta Air Lines (DAL) downgraded to Hold from Buy at Argus with analyst John Staszark saying that while Delta is among the best managed airlines, he thinks better returns are available elsewhere, as Delta is facing prospects for rising costs and slowing revenue growth. 4. PG&E (PCG) downgraded to Sell from Neutral at Citi with analyst Praful Mehta seeing a 75% chance of the stock going to zero after Judge Montali terminated PG&E's exclusive right to advance a plan of reorganization. 5. Canopy Growth (CGC) downgraded to Underperform from Hold at Jefferies with analyst Owen Bennett saying despite the recent selloff in shares, Canopy is the most expensive name across the cannabis space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/19
SPHN
10/14/19
DOWNGRADE
SPHN
Equal Weight
Delta Air Lines downgraded to Equal Weight from Overweight at Stephens
10/14/19
SPHN
10/14/19
DOWNGRADE
Target $57
SPHN
Equal Weight
Delta Air Lines downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Jack Atkins downgraded Delta Air Lines to Equal Weight from Overweight with a price target of $57, down from $75. Investors are "understandably frustrated" that despite a highly favorable operating environment this year, Delta is unable to more aggressively drive yields higher, Atkins tells investors in a research note. In addition, the company, for the third time in the last four years, has raised its unit cost outlook for the second half of the year, adds the analyst. As a result, he believes fiscal 2020 consensus estimates are too high and may need to come down "materially" given the uncertainty around Delta's domestic yields and the impact to fuel prices from IMO 2020. Atkins does not see the stock re-rating higher in this environment.
10/11/19
RAJA
10/11/19
NO CHANGE
Target $64
RAJA
Outperform
Delta Air Lines price target lowered to $64 from $70 at Raymond James
Raymond James analyst Savanthi Syth lowered her price target for Delta Airlines to $64 from $70 following the company's Q3 results, saying the report underperformed peers due to elevated idiosyncratic costs. Domestic revenue trends appear stable, Syth tells investors in a research note and with elevated costs now factored in, she expects its mid-December investor day to create favorable momentum for shares. Syth reiterated her Outperform rating on the shares due to its attractive valuation, strong balance sheet, and her view that structural advantages will allow Delta to retain its relative operational and financial leadership vs. legacy peers.
TOL Toll Brothers
$39.32

-0.17 (-0.43%)

10/14/19
SUSQ
10/14/19
DOWNGRADE
Target $42
SUSQ
Neutral
Toll Brothers downgraded to Neutral at Susquehanna
As reported previously, Susquehanna analyst Jack Micenko downgraded Toll Brothers to Neutral from Positive. The analyst said the shares have outperformed the S&P and are now at the high end of their historical average forward P/E. He lowered his estimates as he tapered his outlook for sales pace improvement and operating leverage through next year. Micenko maintained his $42 price target on Toll Brothers shares.
09/25/19
RAJA
09/25/19
UPGRADE
Target $45
RAJA
Outperform
Toll Brothers upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Buck Horne upgraded KB Home (KBH), Lennar (LEN) and Toll Brothers (TOL) to Outperform from Market Perform ahead of upcoming earnings announcements that he believes will reveal "decidedly improved" housing fundamentals and potential upside to current consensus fiscal 2020 estimates. Data in August demonstrated an inflection in supply and pricing conditions, revealing a "far more bullish backdrop" for homebuilders into year-end, Horne tells investors in a research note. M.D.C. Holdings (MDC) remains the analyst's top homebuilding idea with a Strong Buy rating. He has a $45 price target for Toll Brothers shares.
09/25/19
09/25/19
UPGRADE

Fly Intel: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Berry Global (BERY) upgraded to Buy on valuation at BofA/Merrill with analyst George Staphos saying he thinks the shares now reflect "a pessimistic, mid-single digit perpetuity decline rate" and concerns on plastics that have been a headwind for sector multiples. 2. Toll Brothers (TOL), Lennar (LEN), and KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James. 3. BancorpSouth (BXS) upgraded to Buy from Hold at SunTrust with analyst Jennifer Demba saying she is positive on the company's "steady" small bank acquisition strategy and its "less asset sensitive" balance sheet, adding that its large mortgage and insurance business help to offset the interest rate related challenges in spread income. 4. Siemens (SIEGY) upgraded to Buy from Hold at HSBC with analyst Michael Hagmann saying with its "Vision 2020+," he believes that before the end of the next decade, Siemens will largely consist of the constituents of Digital Industries, Smart Infrastructure and IIoT related activities such as Mindsphere & Digital Services as well as Siemens Integration Services and separately listed Siemens Healthineers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/19
SUSQ
10/14/19
DOWNGRADE
SUSQ
Neutral
Toll Brothers downgraded to Neutral from Positive at Susquehanna
CGC Canopy Growth
$18.66

-0.76 (-3.91%)

10/14/19
GHSC
10/14/19
DOWNGRADE
GHSC
Neutral
Canopy, Hexo downgraded to Neutral as Seaport Global cuts cannabis estimates
Seaport Global analyst Brett Hundley lowered his sales and earnings forecasts for the conventional Canadian cannabis companies he covers as part of a broader reset of expectations for the Canadian cannabis space. As part of the broader changes, he downgraded Canopy Growth (CGC) and Hexo Corp. (HEXO), both to Neutral from Buy. Hundley has lowered his FY21 view for Canopy's revenue to $475.5M and his EBITDA forecast to ($75.1M), adding that he no longer feels confident in the company's potential to receive incremental equity warrant funding from Constellation (STZ) in the near-term. For Hexo, he now sees FY21 revenue of $121.7M and $0.2M in EBITDA. He expects market pricing to become "considerably more challenged" as industry production funnels into "a limited store set" in Canada, Hundley tells investors. He keeps a Buy rating on Aphria (APHA), making it his only Buy-rated conventional Canadian cannabis company, though he cut his price target on the stock to $8 from $13. Hundley has Neutral ratings on Aurora Cannabis (ACB) and Tilray (TLRY).
10/11/19
JEFF
10/11/19
UPGRADE
JEFF
Hold
Jefferies upgrades Hexo to Hold, says pressures now understood
Jefferies analyst Owen Bennett upgraded Hexo (HEXO) to Hold from Underperform with a price target of $2.90. The pressures facing the company are now better understood following its weaker than expected outlook, Bennett tells investors in a research note. The analyst this morning also downgraded Canopy Growth (CGC) to Underperform from Hold. His top picks Cannabis are Aurora Cannabis (ACB), Aphria (APHA) and Green Organic Dutchman (TGODF).
10/14/19
GHSC
10/14/19
DOWNGRADE
GHSC
Neutral
Canopy Growth downgraded to Neutral from Buy at Seaport Global
HEXO Hexo
$2.38

-0.155 (-6.11%)

10/14/19
GHSC
10/14/19
DOWNGRADE
GHSC
Neutral
Hexo downgraded to Neutral from Buy at Seaport Global
10/11/19
ROTH
10/11/19
DOWNGRADE
Target $3
ROTH
Neutral
Roth Capital downgrades Hexo to Neutral after guidance pulled
As previously reported, Roth Capital analyst Scott Fortune downgraded Hexo to Neutral from Buy with a price target of $3.00, down from $10.00, after the company pre-announced weak Q4 revenue and withdrew its 2020 outlook. Hexo, which Fortune contends "has always had a good pulse on the political and regulatory environment for cannabis in Canada," called out the legal cannabis industry's issues there and the analyst said legal access to the Canadian cannabis market remains materially underserved, which he does not see changing in the near-term. As of May, Canada's planned or operating retail locations are "about 90% short of matching the store density of a state such as Colorado," Fortune added in his downgrade note.
10/11/19
10/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Heather Bellini saying recent partner checks suggest accelerating momentum in the company's cloud based financial migrations. 2. Perrigo (PRGO) upgraded to Buy from Hold at Argus with analyst Jasper Hellweg stating that given his expectation that the company will begin to show initial results from its consumer-focused transition later in the year, shares appear attractively valued at 13.1-times his 2019 EPS estimates. 3. Square (SQ) upgraded to Positive from Neutral at Susquehanna with analyst James Friedman noting the stock's underperformance was due to valuation, decelerating margin expansion and decelerating GPV growth and saying he sees the company's return on margin reinvestment on the horizon. 4. Hexo (HEXO) upgraded to Hold from Underperform at Jefferies with analyst Owen Bennett stating the pressures facing the company are now better understood following its weaker than expected outlook. 5. USA Technologies (USAT) upgraded to Buy from Hold at Lake Street with analyst Jaeson Schmidt saying the company's filing of audited financials earlier this week, while containing a lot of moving parts, is a net positive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

APEI

American Public Education

$23.86

0.4 (1.71%)

16:27
11/12/19
11/12
16:27
11/12/19
16:27
Earnings
American Public Education sees Q3 EPS 35c-40c, consensus 37c »

Sees Q4 revenues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FCPT

Four Corners Property Trust

$26.95

-0.16 (-0.59%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Hot Stocks
Four Corners Property Trust acquires Buffalo Wild Wings property for $2M »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WKHS

Workhorse Group

$2.73

-0.155 (-5.38%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Hot Stocks
Workhorse Group announces CFO Paul Gaitan steps down »

Workhorse Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 25

    Nov

SENS

Senseonics

$1.02

-0.08 (-7.31%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Earnings
Senseonics reports Q3 EPS (10c), consensus (16c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HIIQ

Health Insurance Innovations

$23.50

-1.48 (-5.92%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Earnings
Health Insurance Innovations sees FY19 EPS f $4.10-$4.35, consensus $4.09 »

The Company reaffirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

VCTR

Victory Capital

$17.98

0.68 (3.93%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Hot Stocks
Victory Capital reports AUM of $146.8B as of October 31 »

Victory Capital reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$39.04

0.7 (1.83%)

16:26
11/12/19
11/12
16:26
11/12/19
16:26
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$20.39

-2.845 (-12.24%)

16:25
11/12/19
11/12
16:25
11/12/19
16:25
Downgrade
Intelsat rating change  »

Intelsat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

APEI

American Public Education

$23.86

0.4 (1.71%)

16:25
11/12/19
11/12
16:25
11/12/19
16:25
Earnings
American Public Education reports Q3 adjusted EPS 11c, consensus 0c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MORF

Morphic Holding

$15.20

-0.24 (-1.55%)

16:25
11/12/19
11/12
16:25
11/12/19
16:25
Earnings
Morphic Holding reports Q3 EPS (30c), consensus (40c) »

Reports Q3 revenue $5.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MN

Manning & Napier

$1.70

0.005 (0.29%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Hot Stocks
Manning & Napier reports preliminary AUM $19.3B as of October 31 »

Compared with $20.5B at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$25.69

-0.61 (-2.32%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Initiation
Juniper initiated  »

Juniper assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

CHMI

Cherry Hill Mortgage

$14.40

0.385 (2.75%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Earnings
Cherry Hill Mortgage reports Q3 core EPS 41c, consensus 43c »

"We were very active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CYBR

CyberArk

$115.30

1.45 (1.27%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Syndicate
Breaking Syndicate news story on CyberArk »

CyberArk announces $500M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCAT

Health Catalyst

$33.43

-1.18 (-3.41%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Earnings
Health Catalyst sees FY19 revenue $151.1M-$154.4M, consensus $150.7M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 03

    Dec

HIIQ

Health Insurance Innovations

$23.50

-1.48 (-5.92%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Earnings
Health Insurance Innovations reports Q EPS 66c, consensus 32c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SCSC

Scansource

$33.87

-0.16 (-0.47%)

16:24
11/12/19
11/12
16:24
11/12/19
16:24
Earnings
Scansource sees Q2 EPS 80c-85c, consensus 88c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

AB

AllianceBernstein

$29.55

0.26 (0.89%)

16:23
11/12/19
11/12
16:23
11/12/19
16:23
Hot Stocks
AllianceBernstein reports preliminary AUM $601B as of October 31 »

Up from $592B at the end…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 22

    Nov

HCAT

Health Catalyst

$33.43

-1.18 (-3.41%)

16:23
11/12/19
11/12
16:23
11/12/19
16:23
Earnings
Health Catalyst sees Q4 revenue $40M-$43M, consensus $41.2M »

Sees Q4 Adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 03

    Dec

ARMP

Armata Pharmaceuticals

$4.59

0.055 (1.21%)

16:23
11/12/19
11/12
16:23
11/12/19
16:23
Earnings
Armata Pharmaceuticals reports Q3 EPS (73c), consensus (45c) »

As of September 30 Armata…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

REPL

Replimune Group

$16.66

-0.47 (-2.74%)

16:22
11/12/19
11/12
16:22
11/12/19
16:22
Syndicate
Replimune Group files to sell 5M shares of common stock »

J.P. Morgan Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

BLFS

BioLife Solutions

$16.58

-0.28 (-1.66%)

16:22
11/12/19
11/12
16:22
11/12/19
16:22
Earnings
Breaking Earnings news story on BioLife Solutions »

BioLife Solutions sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

AAPL

Apple

$261.89

-0.27 (-0.10%)

16:22
11/12/19
11/12
16:22
11/12/19
16:22
Initiation
Apple initiated  »

RBC starts Apple with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXLA

Axcella

$4.00

-0.02 (-0.50%)

16:22
11/12/19
11/12
16:22
11/12/19
16:22
Earnings
Axcella Health reports Q3 EPS (75c), consensus (71c) »

"We are excited by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLFS

BioLife Solutions

$16.58

-0.28 (-1.66%)

16:22
11/12/19
11/12
16:22
11/12/19
16:22
Earnings
BioLife Solutions raises FY19 revenue view to $27.5M-$31.5M from $27.5M-$30.5M »

Gross margin is now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.